{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:45:37Z","timestamp":1788929137611,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2015_A171"],"award-info":[{"award-number":["2015_A171"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12020-016-0983-9","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T03:11:02Z","timestamp":1463195462000},"page":"198-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Worsening of lipid metabolism after successful treatment of primary aldosteronism"],"prefix":"10.1007","volume":"54","author":[{"given":"Christian","family":"Adolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Asbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Stephanie","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Treitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Ladurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"issue":"9","key":"983_CR1","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser, W.F. Young, V.M. Montori Jr, S. Endocrine, Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metabol. 93(9), 3266\u20133281 (2008). doi: 10.1210\/jc.2008-0104","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"11","key":"983_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, M.J. Mattarello, A. Moretti, G. Palumbo, G. Parenti, E. Porteri, A. Semplicini, D. Rizzoni, E. Rossi, M. Boscaro, A.C. Pessina, F. Mantero, P.S. Investigators, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48(11), 2293\u20132300 (2006). doi: 10.1016\/j.jacc.2006.07.059","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"983_CR3","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"J.W. Conn, Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 45(1), 3\u201317 (1955)","journal-title":"J. Lab. Clin. Med."},{"issue":"8","key":"983_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45(8), 1243\u20131248 (2005). doi: 10.1016\/j.jacc.2005.01.015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12 Pt 2","key":"983_CR5","first-page":"1801","volume":"13","author":"JM Halimi","year":"1995","unstructured":"J.M. Halimi, A. Mimran, Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J. Hypertens. 13(12 Pt 2), 1801\u20131802 (1995)","journal-title":"J. Hypertens."},{"issue":"12","key":"983_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.bbadis.2010.08.005","volume":"1802","author":"JW Funder","year":"2010","unstructured":"J.W. Funder, M. Reincke, Aldosterone: a cardiovascular risk factor? Biochim. Biophys. Acta. 1802(12), 1188\u20131192 (2010). doi: 10.1016\/j.bbadis.2010.08.005","journal-title":"Biochim. Biophys. Acta."},{"issue":"2","key":"983_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-5347(17)58376-7","volume":"117","author":"DN Danforth Jr","year":"1977","unstructured":"D.N. Danforth Jr, M.M. Orlando, F.C. Bartter, N. Javadpour, Renal changes in primary aldosteronism. J. Urol. 117(2), 140\u2013144 (1977)","journal-title":"J. Urol."},{"issue":"5","key":"983_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"G. Hanslik, H. Wallaschofski, A. Dietz, A. Riester, M. Reincke, B. Allolio, K. Lang, I. Quack, L.C. Rump, H.S. Willenberg, F. Beuschlein, M. Quinkler, A. Hannemann, Participants of the German Conn\u2019s, R.: Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 173(5), 665\u2013675 (2015). doi: 10.1530\/EJE-15-0450","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"issue":"4","key":"983_CR9","first-page":"187","volume":"101","author":"A Kreze Sr","year":"2000","unstructured":"A. Kreze Sr, E. Kreze-Spirova, M. Mikulecky, Diabetes mellitus in primary aldosteronism. Bratisl. Lek. Listy 101(4), 187\u2013190 (2000)","journal-title":"Bratisl. Lek. Listy"},{"key":"983_CR10","doi-asserted-by":"publisher","unstructured":"M. Reincke, C. Meisinger, R. Holle, M. Quinkler, S. Hahner, F. Beuschlein, M. Bidlingmaier, J. Seissler, S. Endres. Participants of the German Conn\u2019s, R.: Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s Registry. Hormone and metabolic research\u00a0=\u00a0Hormon- und Stoffwechselforschung\u00a0=\u00a0Hormones et metabolisme 42(6), 435\u2013439 (2010). doi: 10.1055\/s-0029-1246189","DOI":"10.1055\/s-0029-1246189"},{"issue":"2","key":"983_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","volume":"183","author":"W Chen","year":"2014","unstructured":"W. Chen, F. Li, C. He, Y. Zhu, W. Tan, Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir. J. Med. Sci. 183(2), 283\u2013291 (2014). doi: 10.1007\/s11845-013-1007-x","journal-title":"Ir. J. Med. Sci."},{"key":"983_CR12","doi-asserted-by":"publisher","unstructured":"F. Fallo, C. Pilon, R. Urbanet. Primary aldosteronism and metabolic syndrome. Hormone and metabolic research\u00a0=\u00a0Hormon- und Stoffwechselforschung\u00a0=\u00a0Hormones et metabolisme 44(3), 208\u2013214 (2012). doi: 10.1055\/s-0031-1295412","DOI":"10.1055\/s-0031-1295412"},{"issue":"6","key":"983_CR13","first-page":"603","volume":"50","author":"J Widimsky Jr","year":"2001","unstructured":"J. Widimsky Jr, B. Strauch, G. Sindelka, J. Skrha, Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol. Res. Acad. Scientiarum Bohemoslov. 50(6), 603\u2013607 (2001)","journal-title":"Physiol. Res. Acad. Scientiarum Bohemoslov."},{"issue":"4","key":"983_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","volume":"53","author":"J Matrozova","year":"2009","unstructured":"J. Matrozova, O. Steichen, L. Amar, S. Zacharieva, X. Jeunemaitre, P.F. Plouin, Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53(4), 605\u2013610 (2009). doi: 10.1161\/HYPERTENSIONAHA.108.122002","journal-title":"Hypertension"},{"issue":"12","key":"983_CR15","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00268-015-3197-z","volume":"39","author":"M Kaga","year":"2015","unstructured":"M. Kaga, T. Utsumi, T. Tanaka, T. Kono, H. Nagano, K. Kawamura, N. Kamiya, T. Imamoto, N. Nihei, Y. Naya, H. Suzuki, T. Ichikawa, Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism. World J. Surg. 39(12), 2935\u20132940 (2015). doi: 10.1007\/s00268-015-3197-z","journal-title":"World J. Surg."},{"issue":"6","key":"983_CR16","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","volume":"98","author":"E Fischer","year":"2013","unstructured":"E. Fischer, C. Adolf, A. Pallauf, C. Then, M. Bidlingmaier, F. Beuschlein, J. Seissler, M. Reincke, Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J. Clin. Endocrinol. Metabol. 98(6), 2513\u20132520 (2013). doi: 10.1210\/jc.2012-3934","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"983_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","volume":"12","author":"E Fischer","year":"2011","unstructured":"E. Fischer, F. Beuschlein, M. Bidlingmaier, M. Reincke, Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev. Endocr. Metab. Disord. 12(1), 43\u201348 (2011). doi: 10.1007\/s11154-011-9163-7","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"12","key":"983_CR18","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","volume":"33","author":"J Manolopoulou","year":"2015","unstructured":"J. Manolopoulou, E. Fischer, A. Dietz, S. Diederich, D. Holmes, R. Junnila, P. Grimminger, M. Reincke, A. Morganti, M. Bidlingmaier, Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J. Hypertens. 33(12), 2500\u20132511 (2015). doi: 10.1097\/HJH.0000000000000727","journal-title":"J. Hypertens."},{"issue":"12","key":"983_CR19","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1210\/jc.2014-2788","volume":"99","author":"M Haase","year":"2014","unstructured":"M. Haase, A. Riester, P. Kropil, S. Hahner, C. Degenhart, H.S. Willenberg, M. Reincke, Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy. J. Clin. Endocrinol. Metabol. 99(12), 4397\u20134402 (2014). doi: 10.1210\/jc.2014-2788","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"983_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-11-0287","volume":"165","author":"MJ Betz","year":"2011","unstructured":"M.J. Betz, C. Degenhart, E. Fischer, A. Pallauf, V. Brand, U. Linsenmaier, F. Beuschlein, M. Bidlingmaier, M. Reincke, Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 165(2), 301\u2013306 (2011). doi: 10.1530\/EJE-11-0287","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"983_CR21","doi-asserted-by":"publisher","unstructured":"O. Vonend, N. Ockenfels, X. Gao, B. Allolio, K. Lang, K. Mai, I. Quack, A. Saleh, C. Degenhart, J. Seufert, L. Seiler, F. Beuschlein, M. Quinkler, P. Podrabsky, M. Bidlingmaier, R. Lorenz, M. Reincke, L.C. Rump. German Conn\u2019s, R.: Adrenal venous sampling: evaluation of the German Conn\u2019s registry. Hypertension 57(5), 990\u2013995 (2011). doi: 10.1161\/HYPERTENSIONAHA.110.168484","DOI":"10.1161\/HYPERTENSIONAHA.110.168484"},{"issue":"9","key":"983_CR22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, E.P.I. Ckd, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604\u2013612 (2009)","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"983_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, M. Boscaro, Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J. Hypertens. 25(1), 177\u2013186 (2007). doi: 10.1097\/HJH.0b013e3280108e6f","journal-title":"J. Hypertens."},{"issue":"4","key":"983_CR24","first-page":"503","volume":"52","author":"B Strauch","year":"2003","unstructured":"B. Strauch, J. Widimsky, G. Sindelka, J. Skrha, Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol. Res. Acad. Scientiarum Bohemoslov. 52(4), 503\u2013506 (2003)","journal-title":"Physiol. Res. Acad. Scientiarum Bohemoslov."},{"issue":"10","key":"983_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2003.12.049","volume":"43","author":"G Schillaci","year":"2004","unstructured":"G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi, C. Porcellati, E. Mannarino, Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43(10), 1817\u20131822 (2004). doi: 10.1016\/j.jacc.2003.12.049","journal-title":"J. Am. Coll. Cardiol."},{"key":"983_CR26","doi-asserted-by":"publisher","unstructured":"K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr. International Diabetes Federation Task Force on, E., Prevention, Hational Heart, L., Blood, I., American Heart, A., World Heart, F., International Atherosclerosis, S., International Association for the Study of, O.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20131645 (2009). doi: 10.1161\/CIRCULATIONAHA.109.192644","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"3","key":"983_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1210\/jc.2008-1851","volume":"94","author":"M Reincke","year":"2009","unstructured":"M. Reincke, L.C. Rump, M. Quinkler, S. Hahner, S. Diederich, R. Lorenz, J. Seufert, C. Schirpenbach, F. Beuschlein, M. Bidlingmaier, C. Meisinger, R. Holle, S. Endres, Participants of German Conn\u2019s, R.: risk factors associated with a low glomerular filtration rate in primary aldosteronism. J. Clin. Endocrinol. Metabol. 94(3), 869\u2013875 (2009). doi: 10.1210\/jc.2008-1851","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"983_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1210\/jc.2013-2180","volume":"99","author":"Y Iwakura","year":"2014","unstructured":"Y. Iwakura, R. Morimoto, M. Kudo, Y. Ono, K. Takase, K. Seiji, Y. Arai, Y. Nakamura, H. Sasano, S. Ito, F. Satoh, Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J. Clin. Endocrinol. Metabol. 99(5), 1593\u20131598 (2014). doi: 10.1210\/jc.2013-2180","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"983_CR29","doi-asserted-by":"crossref","unstructured":"V.C. Wu, C.C. Kuo, S.M. Wang, K.L. Liu, K.H. Huang, Y.H. Lin, T.S. Chu, H.W. Chang, C.Y. Lin, C.T. Tsai, L.Y. Lin, S.C. Chueh, T.W. Kao, Y.M. Chen, W.C. Chiang, T.J. Tsai, Y.L. Ho, S.L. Lin, W.J. Wang, K.D. Wu, T.S. Group. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J. Hypertens. 29(9)1778\u20131786 (2011). doi:10.1097\/HJH.0b013e3283495cbb","DOI":"10.1097\/HJH.0b013e3283495cbb"},{"issue":"22","key":"983_CR30","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"L.A. Sechi, M. Novello, R. Lapenna, S. Baroselli, E. Nadalini, G.L. Colussi, C. Catena, Long-term renal outcomes in patients with primary aldosteronism. JAMA 295(22), 2638\u20132645 (2006). doi: 10.1001\/jama.295.22.2638","journal-title":"JAMA"},{"issue":"5","key":"983_CR31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1681\/ASN.2004100878","volume":"16","author":"J Ribstein","year":"2005","unstructured":"J. Ribstein, G. Du Cailar, P. Fesler, A. Mimran, Relative glomerular hyperfiltration in primary aldosteronism. J. Am. Soc. Nephrol. 16(5), 1320\u20131325 (2005). doi: 10.1681\/ASN.2004100878","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"983_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1210\/jcem-47-6-1173","volume":"47","author":"A Goldberg","year":"1978","unstructured":"A. Goldberg, D.J. Sherrard, J.D. Brunzell, Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism. J. Clin. Endocrinol. Metabol. 47(6), 1173\u20131182 (1978). doi: 10.1210\/jcem-47-6-1173","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"983_CR33","doi-asserted-by":"publisher","first-page":"E676","DOI":"10.1152\/ajpendo.00364.2001","volume":"283","author":"K Liang","year":"2002","unstructured":"K. Liang, N.D. Vaziri, Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure. Am. J. Physiol. Endocrinol Metabol. 283(4), E676\u2013E681 (2002). doi: 10.1152\/ajpendo.00364.2001","journal-title":"Am. J. Physiol. Endocrinol Metabol."},{"issue":"8","key":"983_CR34","first-page":"S26","volume":"13","author":"GF Guarnieri","year":"1978","unstructured":"G.F. Guarnieri, M. Moracchiello, L. Campanacci, F. Ursini, L. Ferri, M. Valente, C. Gregolin. Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia. Kidney Int. Suppl. 13(8), S26\u2013S30 (1978)","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"983_CR35","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1046\/j.1523-1755.2003.00285.x","volume":"64","author":"H Kimura","year":"2003","unstructured":"H. Kimura, R. Miyazaki, T. Imura, S. Masunaga, S. Suzuki, F. Gejyo, H. Yoshida, Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels. Kidney Int. 64(5), 1829\u20131837 (2003). doi: 10.1046\/j.1523-1755.2003.00285.x","journal-title":"Kidney Int."},{"issue":"4","key":"983_CR36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/014107680009300406","volume":"93","author":"A Majumdar","year":"2000","unstructured":"A. Majumdar, D.C. Wheeler, Lipid abnormalities in renal disease. J. R. Soc. Med. 93(4), 178\u2013182 (2000)","journal-title":"J. R. Soc. Med."},{"issue":"4","key":"983_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1056\/NEJM196807252790403","volume":"279","author":"JD Bagdade","year":"1968","unstructured":"J.D. Bagdade, D. Porte Jr, E.L. Bierman, Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N. Engl. J. Med. 279(4), 181\u2013185 (1968). doi: 10.1056\/NEJM196807252790403","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"983_CR38","first-page":"176","volume":"91","author":"JD Bagdade","year":"1978","unstructured":"J.D. Bagdade, E. Yee, D.E. Wilson, Shafrir: hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl. J. Lab. Clin. Med. 91(1), 176\u2013186 (1978)","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"983_CR39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1981.62","volume":"19","author":"MK Chan","year":"1981","unstructured":"M.K. Chan, Z. Varghese, J.F. Moorhead, Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int. 19(5), 625\u2013637 (1981)","journal-title":"Kidney Int."},{"issue":"2","key":"983_CR40","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"N.D. Vaziri, Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am. J. Physiol. Renal Physiol. 290(2), F262\u2013F272 (2006). doi: 10.1152\/ajprenal.00099.2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"983_CR41","doi-asserted-by":"crossref","unstructured":"K. Matsushita, J. Coresh, Y. Sang, J. Chalmers, C. Fox, E. Guallar, T. Jafar, S.K. Jassal, G.W. Landman, P. Muntner, P. Roderick, T. Sairenchi, B. Schottker, A. Shankar, M. Shlipak, M. Tonelli, J. Townend, A. van Zuilen, K. Yamagishi, K. Yamashita, R. Gansevoort, M. Sarnak, D.G. Warnock, M. Woodward, J. Arnlov, C.K.D.P. Consortium. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. The lancet. Diabet. Endocrinol. 3(7), 514\u2013525 (2015). doi:10.1016\/S2213-8587(15)00040-6","DOI":"10.1016\/S2213-8587(15)00040-6"},{"issue":"7","key":"983_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","volume":"112","author":"J Arnlov","year":"2005","unstructured":"J. Arnlov, J.C. Evans, J.B. Meigs, T.J. Wang, C.S. Fox, D. Levy, E.J. Benjamin, R.B. D\u2019Agostino, R.S. Vasan, Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112(7), 969\u2013975 (2005). doi: 10.1161\/CIRCULATIONAHA.105.538132","journal-title":"Circulation"},{"issue":"1","key":"983_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, L.A. Sechi, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168(1), 80\u201385 (2008). doi: 10.1001\/archinternmed.2007.33","journal-title":"Arch. Intern. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0983-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0983-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T13:34:31Z","timestamp":1567863271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0983-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0983-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}